Ala-Glu-Asp-Pro · Cardiovascular Peptide
Cardiovascular bioregulator — heart and blood vessel protection.
FDA
Research Only
WADA
Not Listed
HALF-LIFE
Unknown
ROUTE
SubQ injection
SCHEDULE
Daily (10-day cycle)
In Plain English
Cardiovascular bioregulator — heart and blood vessel protection.
Status & Legality
NATTY?
No Test ExistsNo established test exists for this compound.
FDA
Research OnlyFor research purposes only. Not FDA approved.
WADA
Not ListedNot currently on WADA prohibited list.
COMPOUNDING
Not from pharmaciesNot available from licensed compounding pharmacies.
PRESCRIBED
Not prescribedNot prescribed in conventional medicine.
ROUTE
SubQ injectionAdministration via subq injection.
Cardiovascular protection
Cardiomyocyte regeneration
Anti-aging
Cortagen is a tetrapeptide bioregulator designed for the cardiovascular system. Russian research demonstrates protection of cardiomyocytes from ischemic damage, improved cardiac function in elderly patients, and reduction in cardiovascular mortality as part of peptide bioregulator protocols.
Mild injection site reaction
Very well tolerated in studies
Skipping SubQ or IM injection and seeking oral alternatives — Cortagen is not bioavailable orally
Using short-term without understanding the cyclical protocol — benefits are cumulative over repeated annual cycles
Expecting dramatic heart disease reversal — Cortagen is preventive and cardiomyocyte-protective, not a treatment for established disease
Cardiac medications (beta blockers, ACE inhibitors) — generally safe; may have additive cardiovascular protective effects
Anticoagulants — monitor carefully; injection site bruising may increase
No known adverse drug interactions at standard research doses
Cortagen is for cardiovascular longevity — always part of a protocol, not a standalone treatment. The Russian clinical data shows consistent cardiomyocyte protection when run in the 10-day cycle protocol twice yearly. If cardiovascular health is a priority, add it to the Epithalon + Thymalin baseline protocol.
Stats
Sources & Studies
Cardioprotective effects of the tetrapeptide cortagen on isolated rat heart
Khavinson VKh. et al., Bull Exp Biol Med, 2003